Frontiers in Microbiology,
Journal Year:
2020,
Volume and Issue:
11
Published: Jan. 31, 2020
Iron
is
a
micronutrient
for
nearly
all
life
on
Earth.
It
can
be
used
as
an
electron
donor
and
acceptor
by
iron-oxidizing
iron-reducing
microorganisms
in
variety
of
biological
processes,
including
photosynthesis
respiration.
While
it
the
fourth
most
abundant
metal
Earth's
crust,
iron
often
limiting
growth
oxic
environments
because
readily
oxidized
precipitated.
Much
our
understanding
how
compete
utilize
based
laboratory
experiments.
However,
advent
next-generation
sequencing
surge
publicly
available
sequence
data
has
made
possible
to
probe
structure
function
microbial
communities
environment.
To
bridge
gap
between
acquisition,
redox
cycling,
storage,
magnetosome
formation
model
plethora
from
environmental
studies,
we
have
created
comprehensive
database
hidden
Markov
models
(HMMs)
genes
related
reduction/oxidation
Bacteria
Archaea.
Along
with
this
database,
present
FeGenie,
bioinformatics
tool
that
accepts
genome
metagenome
assemblies
input
uses
HMM
annotate
provided
datasets
respect
iron-related
gene
neighborhood.
An
important
contribution
efficient
identification
involved
oxidation
dissimilatory
reduction,
which
been
largely
overlooked
standard
annotation
pipelines.
We
validated
FeGenie
against
selected
set
28
isolate
genomes
showcase
its
utility
exploring
27
metagenomes,
4
human
oral
biofilms,
17
candidate
organisms,
members
phyla
radiation.
show
accurately
identifies
isolates.
Furthermore,
analysis
metagenomes
using
demonstrates
repertoire
abundance
each
environment
correlated
richness.
will
not
replace
reliability
culture-dependent
analyses
physiology,
provides
reliable
predictions
derived
up-to-date
genetic
markers.
FeGenie's
maintained
continually
updated
new
are
discovered.
freely
available:
https://github.com/Arkadiy-Garber/FeGenie.
Journal of Natural Products,
Journal Year:
2016,
Volume and Issue:
79(3), P. 629 - 661
Published: Feb. 7, 2016
This
contribution
is
a
completely
updated
and
expanded
version
of
the
four
prior
analogous
reviews
that
were
published
in
this
journal
1997,
2003,
2007,
2012.
In
case
all
approved
therapeutic
agents,
time
frame
has
been
extended
to
cover
34
years
from
January
1,
1981,
December
31,
2014,
for
diseases
worldwide,
1950
(earliest
so
far
identified)
2014
antitumor
drugs
worldwide.
As
mentioned
2012
review,
we
have
continued
utilize
our
secondary
subdivision
"natural
product
mimic",
or
"NM",
join
original
primary
divisions
designation
botanical",
"NB",
those
botanical
"defined
mixtures"
now
recognized
as
drug
entities
by
U.S.
FDA
(and
similar
organizations).
From
data
presented
utilization
natural
products
and/or
their
novel
structures,
order
discover
develop
final
entity,
still
alive
well.
For
example,
area
cancer,
over
around
1940s
end
175
small
molecules
approved,
131,
75%,
are
other
than
"S"
(synthetic),
with
85,
49%,
actually
being
either
directly
derived
therefrom.
areas,
influence
structures
quite
marked,
with,
expected
information,
anti-infective
dependent
on
structures.
We
wish
draw
attention
readers
rapidly
evolving
recognition
significant
number
drugs/leads
produced
microbes
microbial
interactions
"host
whence
it
was
isolated",
therefore
considered
research
should
be
significantly.
Current Opinion in Microbiology,
Journal Year:
2019,
Volume and Issue:
51, P. 72 - 80
Published: Oct. 1, 2019
The
first
antibiotic,
salvarsan,
was
deployed
in
1910.
In
just
over
100
years
antibiotics
have
drastically
changed
modern
medicine
and
extended
the
average
human
lifespan
by
23
years.
discovery
of
penicillin
1928
started
golden
age
natural
product
antibiotic
that
peaked
mid-1950s.
Since
then,
a
gradual
decline
development
evolution
drug
resistance
many
pathogens
has
led
to
current
antimicrobial
crisis.
Here
we
give
an
overview
history
discovery,
major
classes
where
they
come
from.
We
argue
future
looks
bright
as
new
technologies
such
genome
mining
editing
are
discover
products
with
diverse
bioactivities.
also
report
on
state
development,
45
drugs
currently
going
through
clinical
trials
pipeline,
including
several
novel
modes
action
phase
3
trials.
Overall,
there
promising
signs
for
but
changes
financial
models
required
translate
scientific
advances
into
clinically
approved
antibiotics.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY,
Journal Year:
2020,
Volume and Issue:
70(7), P. 3956 - 4042
Published: July 1, 2020
We
here
present
annotated
lists
of
names
Candidatus
taxa
prokaryotes
with
ranks
between
subspecies
and
class,
proposed
the
mid-1990s,
when
provisional
status
was
first
established,
end
2018.
Where
necessary,
corrected
are
that
comply
current
provisions
International
Code
Nomenclature
Prokaryotes
its
Orthography
appendix.
These
lists,
as
well
updated
newly
published
additions
corrections
to
be
periodically
in
Journal
Systematic
Evolutionary
Microbiology,
may
serve
basis
for
valid
publication
if
proposals
expand
type
material
naming
also
include
gene
sequences
yet-uncultivated
is
accepted
by
Committee
on
Systematics
Prokaryotes.